6S Pharma LLC

6S Pharma is an early-stage pharmaceutical startup developing 505(b)(2) repurposed drugs and complex generics across a preclinical pipeline that targets oral mucositis, diabetic foot ulcers, burns, uterine fibroids, Sjogren's syndrome, macular degeneration, leptomeningeal disease, and gastric ulcers. The company is preparing IND filings for two of its products and has out-licensed one complex generic formulation.